Pharma Journalist -

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a binding agreement to expand their existing collaboration to include the research and development of new…
Read More...

Iterion Therapeutics, Inc. ("Iterion"), a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, announced that it has raised $17 million USD in a…
Read More...

Johnson & Johnson announced that Janssen-Cilag International N.V., has submitted a conditional Marketing Authorisation Application (cMAA) to the European Medicines Agency (EMA)…
Read More...

In just the last week few weeks there have been clinical updates from Pfizer, Sarepta and Audentes on their programs in muscular disorders. The timely Gene Therapy for Muscular…
Read More...

Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that animal testing has commenced with two…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved the following expanded indication for Entresto (sacubitril/valsartan): to reduce the risk of…
Read More...

AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions,  announced a new collaboration with AstraZeneca, a global science-led…
Read More...

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new therapies…
Read More...

Avexegen Therapeutics Inc. announced that it has received a Phase 2 award of $2.94 million under the National Institutes of Health's Small Business Innovation Research Program (SBIR)…
Read More...

SMi Reports: SMi Group is proud to introduce some insightful content from our chair and expert speaker of the Pre-filled Syringes East Coast virtual conference 2021 The upcoming…
Read More...